Latest & greatest articles for pulmonary embolism

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pulmonary embolism or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pulmonary embolism and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pulmonary embolism

161. Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians

Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians Evaluation of Patients With Suspected Acute Pulmonary Embolism | Annals of Internal Medicine | American College of Physicians '); } '); })(); Sign in below to access your subscription for full content INDIVIDUAL SIGN IN | You will be directed to acponline.org to register and create your Annals account INSTITUTIONAL SIGN (...) IN | | Subscribe to Annals of Internal Medicine . You will be directed to acponline.org to complete your purchase. Search Clinical Guidelines | 3 November 2015 Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians Free Ali S. Raja, MD; Jeffrey O. Greenberg, MD; Amir Qaseem, MD, PhD, MHA; Thomas D. Denberg, MD, PhD; Nick Fitterman, MD; Jeremiah D. Schuur, MD, MHS; for the Clinical Guidelines Committee

2015 American College of Physicians

162. Can Computed Tomography?Assessed Right-Sided Ventricular Dysfunction Predict Mortality in Hemodynamically Stable Pulmonary Embolism?

Can Computed Tomography?Assessed Right-Sided Ventricular Dysfunction Predict Mortality in Hemodynamically Stable Pulmonary Embolism? Systematic Review Snapshot TAKE-HOME MESSAGE Right-sided ventricular dysfunction assessed by computed tomography (CT) isassociatedwithall-causeshort-termmortalityandmorestronglyassociatedwith mortality caused by pulmonary embolism. Can Computed Tomography–Assessed Right-Sided Ventricular Dysfunction Predict Mortality in Hemodynamically Stable Pulmonary Embolism (...) only hemodynamically stable patients. Five of the included studies were retrospective and 5 were pro- spectively designed. Nine studies de?ned evidence of right-sided ventricular dysfunction similarly, using right-ventricular or left- ventricular-diameter ratios of 0.9 to 1.0, and 1 study de?ned right- sided ventricular dysfunction as a right ventricular/left ventricu- lar ratio greater than 1.5. Only 3 studies reported pulmonary embolism–related mortality as an outcome. Overall mortality Pooled

2015 Annals of Emergency Medicine Systematic Review Snapshots

163. The incidence of pulmonary embolism in emergency department patients, reported by country of study: a systematic review

The incidence of pulmonary embolism in emergency department patients, reported by country of study: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2015 PROSPERO

164. Imaging for the exclusion of pulmonary embolism in pregnancy [Cochrane Protocol]

Imaging for the exclusion of pulmonary embolism in pregnancy [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2015 PROSPERO

165. D-dimer test for excluding the diagnosis of pulmonary embolism [Cochrane Protocol]

D-dimer test for excluding the diagnosis of pulmonary embolism [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2015 PROSPERO

166. Effectiveness and safety of new oral anticoagulants in patients with non-valvular atrial fibrillation, deep vein thrombosis, or pulmonary embolism: a systematic review and meta-analysis

Effectiveness and safety of new oral anticoagulants in patients with non-valvular atrial fibrillation, deep vein thrombosis, or pulmonary embolism: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2015 PROSPERO

167. Systematic review and meta-analysis of findings from 12-lead electrocardiography to risk-stratify patients with acute pulmonary embolism

Systematic review and meta-analysis of findings from 12-lead electrocardiography to risk-stratify patients with acute pulmonary embolism Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2015 PROSPERO

168. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism [Cochrane Protocol]

Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2015 PROSPERO

169. Effectiveness of clinical decision rules for the diagnosis of pulmonary embolism: a systematic review

Effectiveness of clinical decision rules for the diagnosis of pulmonary embolism: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2015 PROSPERO

170. Efficacy and safety outcomes of various revascularization procedures in patients with acute symptomatic pulmonary embolism: systematic review and network meta-analysis

Efficacy and safety outcomes of various revascularization procedures in patients with acute symptomatic pulmonary embolism: systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g

2015 PROSPERO

171. Current antipsychotic drug treatment may increase the risk of pulmonary embolism

Current antipsychotic drug treatment may increase the risk of pulmonary embolism Current antipsychotic drug treatment may increase the risk of pulmonary embolism | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional (...) accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Current antipsychotic drug treatment may increase the risk of pulmonary embolism Article Text Causes and risk factors Current antipsychotic drug treatment may increase the risk of pulmonary embolism Marie Tournier Statistics

2015 Evidence-Based Mental Health

172. Inferior Vena Cava Filters for Prevention of Pulmonary Embolism

Inferior Vena Cava Filters for Prevention of Pulmonary Embolism 1 COVERAGE GUIDANCE: INFERIOR VENA CAVA FILTERS FOR PREVENTION OF PULMONARY EMBOLI Approved March 12, 2015 HERC COVERAGE GUIDANCE Inferior vena cava (IVC) filters are recommended for coverage in: ? Patients with active deep vein thrombosis/pulmonary embolism (DVT/PE) for which anticoagulation is contraindicated (strong recommendation) ? Some hospitalized patients with trauma* (weak recommendation) Retrieval of removable IVC filters (...) -populations-130607.pdf Sobieraj, D.M., Coleman, C.I., Tongbram, V., Lee, S., Colby, J., Chen, W.T., et al. (2012). Venous thromboembolism in orthopedic surgery. Rockville, MD: AHRQ. Retrieved on October 2, 2014, from http://effectivehealthcare.ahrq.gov/ehc/products/186/992/CER- 49_VTE_20120313.pdf Young, T., Tang, H., & Hughes, R. (2010). Vena caval filters for the prevention of pulmonary embolism. Cochrane Database Syst Rev, 2(2). DOI: 10.1002/14651858.CD006212.pub4 Additional sources Decousus, H

2015 Oregon Health Evidence Review Commission

173. Randomised controlled trial: An IVC filter and anticoagulation for 3?months is unlikely to show a benefit over anticoagulation alone for high-risk patients with acute pulmonary embolism

Randomised controlled trial: An IVC filter and anticoagulation for 3?months is unlikely to show a benefit over anticoagulation alone for high-risk patients with acute pulmonary embolism An IVC filter and anticoagulation for 3 months is unlikely to show a benefit over anticoagulation alone for high-risk patients with acute pulmonary embolism | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings (...) months is unlikely to show a benefit over anticoagulation alone for high-risk patients with acute pulmonary embolism Article Text Therapeutics/Prevention Randomised controlled trial An IVC filter and anticoagulation for 3 months is unlikely to show a benefit over anticoagulation alone for high-risk patients with acute pulmonary embolism Eric K Hoffer Statistics from Altmetric.com Commentary on: Mismetti P , Laporte S , Pellerin O , et al ; PREPIC2 Study Group. Effect of a retrievable inferior vena

2015 Evidence-Based Medicine

174. Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism

Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism Dabigatr Dabigatran ete an etexilate for the treatment xilate for the treatment and secondary pre and secondary prev vention of deep v ention of deep vein ein thrombosis and/or pulmonary embolism thrombosis and/or pulmonary embolism T echnology appraisal guidance Published: 17 December 2014 nice.org.uk/guidance/ta327 © NICE 2018. All rights reserved. Subject to Notice of rights (...) and/or pulmonary embolism (TA327) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 48Contents Contents 1 Guidance 4 2 The technology 5 3 The company's submission 6 T able 1 Summary of adverse events in the RE-COVER trials, RE-MEDY and RE-SONATE 8 4 Consideration of the evidence 24 Clinical effectiveness 26 Cost effectiveness 29 Summary of Appraisal Committee's key conclusions 33 5 Implementation 40 6 Review of guidance 41

2015 National Institute for Health and Clinical Excellence - Technology Appraisals

175. Rapid Quantitative D-dimer to Exclude Pulmonary Embolism: A Prospective Cohort Management Study Full Text available with Trip Pro

Rapid Quantitative D-dimer to Exclude Pulmonary Embolism: A Prospective Cohort Management Study ESSENTIALS: It is not known if D-dimer testing alone can safely exclude pulmonary embolism (PE). We studied the safety of using a quantitative latex agglutination D-dimer to exclude PE in 808 patients. 52% of patients with suspected PE had a negative D-dimer test and were followed for 3 months. The negative predictive value of D-dimer testing alone was 99.8%, suggesting it may safely exclude (...) PE.Strategies are needed to exclude pulmonary embolism (PE) efficiently without the need for imaging tests. Although validated rules for clinical probability assessment can be combined with D-dimer testing to safely exclude PE, the rules can be complicated or partially subjective, which limits their use.To determine if PE can be safely excluded in patients with a negative D-dimer without incorporating clinical probability assessment.We enrolled consecutive outpatients and inpatients with suspected PE from

2015 EvidenceUpdates

176. Accuracy of the Wells Clinical Prediction Rule for Pulmonary Embolism in Older Ambulatory Adults (Abstract)

Accuracy of the Wells Clinical Prediction Rule for Pulmonary Embolism in Older Ambulatory Adults To determine whether the Wells clinical prediction rule for pulmonary embolism (PE), which produces a point score based on clinical features and the likelihood of diagnoses other than PE, combined with normal D-dimer testing can be used to exclude PE in older unhospitalized adults.Prospective cohort study.Primary care and nursing homes.Older adults (≥60) clinically suspected of having a PE (N = 294 (...) , mean age 76, 44% residing in a nursing home).The presence of PE was confirmed using a composite reference standard including computed tomography and 3-month follow-up. The proportion of individuals with an unlikely risk of PE was calculated according to the Wells rule (≤4 points) plus a normal qualitative point-of-care D-dimer test (efficiency) and the presence of symptomatic PE during 3 months of follow-up within these patients (failure rate).Pulmonary embolism occurred in 83 participants (28

2014 EvidenceUpdates

177. Outpatient versus inpatient treatment for acute pulmonary embolism. (Abstract)

Outpatient versus inpatient treatment for acute pulmonary embolism. Pulmonary embolism (PE) is a common life-threatening cardiovascular condition, with an incidence of 23 to 69 new cases per 100,000 people per year. Outpatient treatment instead of traditional inpatient treatment in selected non-high-risk patients with acute PE might provide several advantages, such as reduction of hospitalizations, substantial cost saving and an improvement in health-related quality of life.To compare

2014 Cochrane

178. Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study Full Text available with Trip Pro

Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study Patients with polymyositis (PM) and dermatomyositis (DM) may have an increased risk of venous thromboembolism (VTE); however, no general population data are available to date. The purpose of this study was to estimate the future risk and time trends of new VTE (deep venous thrombosis (DVT) or pulmonary embolism (PE)) in individuals with incident PM/DM

2014 EvidenceUpdates

179. PE rule-out criteria (PERC) for excluding pulmonary embolism.

PE rule-out criteria (PERC) for excluding pulmonary embolism. BestBets: PE rule-out criteria (PERC) for excluding pulmonary embolism. PE rule-out criteria (PERC) for excluding pulmonary embolism. Report By: Dr Johan Victor Rehnberg - ACCS (Emergency Medicine) CT2 Search checked by Dr Anna Vondy - Specialist Registrar (Emergency Medicine) Institution: Royal Liverpool University Hospital, Liverpool, UK Date Submitted: 7th November 2012 Date Completed: 26th February 2014 Last Modified: 26th (...) help exclude PE without the need for D-dimer testing. Search Strategy The Cochrane Library issue 10 of 12 October 2013: ‘(Pulmonary Embolism’ [MeSH; explode all trees] AND ‘Diagnosis’ [MeSH term; explode all trees]) OR (‘PERC’ OR ‘PE rule out criteria’ OR ‘Pulmonary embolism rule out criteria’ OR ‘PE rule-out criteria’ OR ‘Pulmonary embolism rule-out criteria’ OR ‘PE rule out’ OR ‘Pulmonary embolism rule out’ OR ‘PE rule-out’ OR ‘Pulmonary embolism rule-out’). Medline/EMBASE from 2004 to 29th

2014 BestBETS

180. Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism Full Text available with Trip Pro

Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism The optimal N-terminal pro-brain natriuretic peptide (NT-proBNP) cut-off value for risk stratification of pulmonary embolism remains controversial. In this study we validated and compared different proposed NT-proBNP cut-off values in 688 normotensive patients with pulmonary embolism. During the first 30 days, 28 (4.1%) patients reached the primary outcome (pulmonary embolism (...) a prognostic impact on top of that of the simplified Pulmonary Embolism Severity Index and right ventricular dysfunction on echocardiography (OR 4.27 (95% CI 1.22-15.01); p=0.024, c-index 0.741). The use of a stepwise approach based on the simplified Pulmonary Embolism Severity Index, NT-proBNP ≥ 600 pg·mL(-1) and echocardiography helped optimise risk assessment. Our findings confirm the prognostic value of NT-proBNP and suggest that a cut-off value of 600 pg·mL(-1) is most appropriate for risk

2014 EvidenceUpdates